Special Issue "Non-invasive Drug Delivery Systems"
Deadline for manuscript submissions: closed (10 October 2020) | Viewed by 32171
Many drugs, including a proportion of small drug molecules, as well as most biologics (peptides, therapeutic proteins, antibodies and nucleic acid-based therapeutics), are currently administered by injection. This is predominantly owing to the poor bioavailability following non-invasive (e.g. oral) administration. Non-invasive drug delivery offers many advantages over injection, including improved patient acceptability and adherence to therapy and potentially enhanced drug safety profile. The reduction in needle-related complications and healthcare costs (associated with administration by healthcare professionals) achieved by non-invasive delivery can present further opportunities for medicines optimization.
Non-invasive drug delivery systems have therefore been researched extensively and significant progress in the field is clearly apparent. With this Special Issue on ‘Non-Invasive Drug Delivery Systems’ it is aimed to present the current state-of-the-art in the field. The areas covered incorporate novel mucosal delivery systems (including but not limited to oral, pulmonary and nasal delivery systems), as well as non-invasive skin delivery systems. Delivery systems include formulations or devices utilised for delivery of drugs which normally require administration by injection (including but not limited to biologics). Research scientists working in this field are therefore invited to contribute by submitting original research articles, review articles or commentaries.
Dr. Driton Vllasaliu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Biologics delivery
- Devices for drug delivery
- Mucosal drug delivery
- Non-invasive drug delivery
- Non-injection drug delivery